- Home
- AXSM vs ESAB Comparison
AXSM vs ESAB Comparison
Compare AXSM & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | ESAB |
|---|---|---|
| Founded | 2012 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.1B |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | AXSM | ESAB |
|---|---|---|
| Price | $160.88 | $98.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $209.18 | $144.13 |
| AVG Volume (30 Days) | ★ 498.6K | 369.1K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | ★ 0.41% |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ 3.67 |
| Revenue | N/A | ★ $2,842,555,000.00 |
| Revenue This Year | $58.34 | $6.42 |
| Revenue Next Year | $54.30 | $5.59 |
| P/E Ratio | ★ N/A | $26.38 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $86.99 | $96.51 |
| 52 Week High | $191.50 | $137.42 |
Technical Indicators
Market Signals| Indicator | AXSM | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 41.54 | 25.47 |
| Support Level | $148.14 | N/A |
| Resistance Level | $169.11 | $118.33 |
| Average True Range (ATR) | 3.98 | 4.38 |
| MACD | -0.60 | -2.31 |
| Stochastic Oscillator | 49.43 | 9.04 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.